ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NAMSW NewAmsterdam Pharma Company NV

9.00
-0.13 (-1.42%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End
EUR (€)
Total Assets
Total Current Assets
Cash and Equivalents
Total Non-Current Assets
Total Liabilities
Total Current Liabilities
Total Non-Current Liabilities
Common Equity
Retained Earnings
Year End December 30 2023 2023
EUR (€)
Total Assets 347.1M
Total Current Assets 346.79M
Cash and Equivalents 340.45M
Total Non-Current Assets 288.39M
Total Liabilities 58.7M
Total Current Liabilities 49.9M
Total Non-Current Liabilities 8.81M
Total Equity 288.39M
Common Equity 10.17M
Retained Earnings -316.97M